Leading Psychiatrists Highlight Breakthrough Technology in Mumbai Discussion
Mumbai, India, April 1, 2025 – In a groundbreaking event held in Mumbai, leading psychiatrists gathered to explore innovative approaches to managing stress and anxiety. Central to the discussion was GoRoga, India's first anti-stress wearable, heralded as a transformative step forward in mental wellness through cutting-edge technology.
Prominent Expert Reveals Impressive Clinical Results
The discussion was led by Dr. Avinash Desousa, Founder and Trustee of Desousa Foundation Mumbai, a renowned mental health specialist. Dr. Desousa shared firsthand insights from clinical practice, emphasizing the impressive outcomes observed with GoRoga:
- Just 20 minutes of daily usage significantly lowered stress and anxiety, confirmed by GAD-7 assessment scores.
- Case Study Highlight: After one week of GoRoga use, one patient successfully reduced smoking from seven cigarettes per day to just three.
- Second Case Study: A 23-year-old male with Bipolar Mood Disorder, who suffered persistent headaches and visual disturbances, achieved relief when conventional migraine treatments had failed.
Highlighting the wearable’s effectiveness, Dr. Desousa stated, "Cranial Electrotherapy Stimulation (CES) is a proven, USFDA-approved technology backed by over four decades of clinical research. GoRoga now makes effective stress management accessible through an easy-to-use, compact device."
Interactive Sessions and Live Demonstrations Impress Professionals
The event also included dynamic Q&A sessions, allowing psychiatrists to delve deeper into the device's clinical efficacy, practical applications, and user experiences. Attendees were invited to live demonstrations, experiencing GoRoga's ease-of-use and potential firsthand, significantly reinforcing their confidence in its capabilities.
Powerful Data Supports GoRoga's Long-term Benefits
A compelling retrospective study involving 100 patients revealed remarkable insights about GoRoga’s effectiveness in addressing stress, anxiety, insomnia, panic attacks, and depression:
- 85% reported a notable decrease in stress levels.
- 73% continued using GoRoga beyond six months, citing sustained benefits.
- 90% enthusiastically recommended the wearable to friends and family, underscoring exceptional user satisfaction.
Dr. Sagar Karia, a prominent Mumbai-based psychiatrist, further endorsed GoRoga during a recent psychiatry conference:
"Even a single session demonstrated remarkable improvements in acute anxiety symptoms. CES represents a promising, non-invasive therapy for stress and anxiety."
Boosting Corporate and Academic Wellness Programs
Tania Mazumdar, Executive Director at GlobalSpace Technologies, shared insights into GoRoga’s successful adoption in the U.S., particularly within corporate wellness initiatives aiming to tackle workplace stress, anxiety, and burnout.
Highlighting its expanding presence in India, Mazumdar revealed that GoRoga is now integrated into stress management programs at one of India’s premier engineering institutes. She emphasized its significant potential to boost productivity and enhance mental well-being in both academic and corporate settings.
GoRoga Officially Launches in India: Pioneering Digital Therapeutics
Initially developed and patented as RogaLife in the USA, GoRoga is now available in India through collaboration with GlobalSpace Technologies Ltd, a leader in digital pharmaceuticals and healthcare innovation for over a decade. This FDA-approved wearable device promises to revolutionize mental health management through advanced digital therapeutics, accessible to a broad spectrum of users nationwide.
Last updated by a enewsx: